BIO89-100 (Pegozafermin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIO89-100 (Pegozafermin), covering 2024-07-25 to 2024-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia [Phase 2]